Research

Hormonal

Tirzepatide is a first in class dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP) analog approved for the management of adult patients with type 2 diabetes mellitus.

Tirzepatide can be prescribed to adults with type 2 diabetes as part of their treatment plan.

StrongSupportsmedium confidence
Tirzepatide is a first in class dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GIP) analog approved for the management of adult patients with type 2 diabetes mellitus as an adjunct to diet and exercise.
Elaine Wong et al. · American Journal of Therapeutics · 2022

Why this rating

Based on the mention of clinical trials and regulatory approval.

Source

Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus

Elaine Wong et al. · American Journal of Therapeutics · 2022

DOI 10.1097/mjt.0000000000001588

reviewCited 8×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →